<DOC>
	<DOCNO>NCT01888575</DOCNO>
	<brief_summary>This study conduct cohort low dose aspirin ( ASA ) users previously ascertain .The aim post hoc analysis : To estimate one year risk discontinuation use low-dose ASA associate PPI concomitant use versus non-use , crude adjust confound . To estimate one year risk discontinuation use low-dose ASA associate PPI concomitant use stratify age sex . To evaluate predictor discontinuation low-dose ASA first year ASA therapy .</brief_summary>
	<brief_title>Assessment Low-dose ASA Discontinuation Risk Associated With Concomitant PPI Use During First Year ASA Therapy</brief_title>
	<detailed_description>Assessment low-dose ASA discontinuation risk associate concomitant PPI use first year ASA therapy secondary prevention</detailed_description>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Patients age 5084 year 20002007 . Patients first prescription low dose ASA ( see study population description ) . Patients require enrolled primary care practitioner ( PCP ) least 2 year computerized prescription history least 1 year start study . Patients age age 50 85 year ( see study population description ) . Patients diagnosis cancer , alcohol abuse alcoholrelated disease . Incomplete data record THIN .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Discontinuation low dose ASA ,</keyword>
	<keyword>Secondary cardiovascular prevention ,</keyword>
	<keyword>Acid-suppressing drug ,</keyword>
	<keyword>Gastrointestinal risk ,</keyword>
	<keyword>Epidemiology</keyword>
</DOC>